Inspiration Healthcare Group PLC SLE 6000 & OxyGenie(R) Japan approval & GBP400k Order (3165S)
March 16 2021 - 2:00AM
UK Regulatory
TIDMIHC
RNS Number : 3165S
Inspiration Healthcare Group PLC
16 March 2021
Inspiration Healthcare Group plc
("Inspiration Healthcare", the "Company" or the "Group")
SLE 6000 and OxyGenie (R) approved for use in Japan
with initial order for c.GBP400,000
Inspiration Healthcare Group plc (AIM: IHC), the global medical
technology company, is pleased to announce that SLE Ltd, the
specialist neonatal ventilator manufacturer it acquired in July
2020, has received Japanese regulatory approval for the enhanced
SLE6000. The approval is for the top of the range SLE6000 model
that includes various features such as enhanced High Frequency
Oscillatory Ventilation designed for use with critically ill
infants as well as the OxyGenie (R) patented oxygen control
algorithm which helps maintain infants at their targeted oxygen
saturation levels, volume targeted ventilation, End-Tidal CO(2)
monitoring and greater non-invasive modes. This product has been
registered for use in Japan and the Company's Japanese distributor
has placed an initial order totalling c.GBP400,000 for immediate
despatch.
Neil Campbell, Chief Executive Officer, commented: "We are
delighted to have received this significant order and the
successful registration of these products in Japan and to see that
our global reach continues to expand as the advanced technologies
we have developed are adopted in the leading neonatal Intensive
care units all over the world."
Enquiries:
Inspiration Healthcare Group plc Tel: 01455 840555
Neil Campbell, Chief Executive Officer
Jon Ballard, Chief Financial Officer
Nominated Adviser & Broker Tel: 0207 397 8900
Cenkos Securities plc
Mark Connelly
Stephen Keys
-------------------
Cadogan PR Tel: 07771 713608
Alex Walters
alex.walters@cadoganpr.com
-------------------
About Inspiration Healthcare http://www.inspiration-healthcare.com
Inspiration Healthcare (AIM: IHC) is a global provider of
medical technology for use in critical care & operating
theatres. The Company provides high-quality, innovative products to
patients around the world which help to improve patient outcomes,
and it actively invests in innovative product opportunities and
disruptive technologies.
Through investment in research and development the Company has
six key own-brand products that can be used within the first 6
hours of life to help premature and sick babies; helping with
assessment, resuscitation, stabilisation as well as preventing
brain damage. Additionally, the Company has a range of products for
maintaining normothermia pre- during and post-surgery.
In September 2019, the Company acquired Vio Holdings a designer,
manufacturer and supplier of single-use respiratory products and
sterile medical consumables for GBP3.7 million and in June 2020 the
Company acquired SLE, a leading global provider of neonatal
ventilation products for GBP18 million. Over 90% of SLE's revenues
are generated from sales outside of the UK with a significant
proportion of these in the Asia Pacific and the Middle East. When
combined, the Group generates approximately 60 per cent. of its
revenue from exports.
With product availability extending to over 50 countries through
a distribution network, Inspiration Healthcare's success has been
built on continuous innovation, excellent customer service and an
inherent commitment to improving patient outcomes, working in close
collaboration with key opinion leaders across the globe.
In the U.K. and Ireland, the Company has a direct sales team
selling Inspiration Healthcare Branded and complementary products
from third parties, with an additional range of home healthcare
products. This is supported by Technical Support for planned
preventative maintenance and emergency assistance.
Further information on Inspiration Healthcare can be seen at www.inspiration-healthcare.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
REAFZGMFVKVGMZM
(END) Dow Jones Newswires
March 16, 2021 03:00 ET (07:00 GMT)
Inspiration Healthcare (LSE:IHC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Inspiration Healthcare (LSE:IHC)
Historical Stock Chart
From Apr 2023 to Apr 2024